Literature DB >> 15140129

Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis.

J Corral1, J A Huntington, R González-Conejero, A Mushunje, M Navarro, P Marco, V Vicente, R W Carrell.   

Abstract

BACKGROUND: Missense mutations causing conformational alterations in serpins can be responsible for protein deficiency associated with human diseases. However, there are few data about conformational consequences of mutations affecting antithrombin, the main hemostatic serpin.
OBJECTIVES: To investigate the conformational and clinical effect of mutations affecting the shutter region of antithrombin. PATIENTS AND METHODS: We identified two families with significant reduction of circulating antithrombin displaying early and severe venous thrombosis, frequently associated with pregnancy or infection. Mutations were determined by standard molecular methods. Biochemical studies were performed on plasma samples. One variant (P80S) was purified by heparin-affinity chromatography and gel filtration, and evaluated by proteomic analysis. Finally, we modelled the structure of the mutant dimer.
RESULTS: We identified two missense mutations affecting the shutter region of antithrombin: P80S and G424R. Carriers of both mutations presented traces of a similar abnormal antithrombin, supporting inefficiently expressed rather than non-expressed variants. The abnormal antithrombin purified from P80S carriers is an inactive disulfide-linked dimer of mutant antithrombin whose properties are consistent with head-to-head insertion of the reactive loop.
CONCLUSIONS: Our data support the conclusion that missense mutations affecting the shutter region of serpins have specific conformational effects resulting in the formation of mutant oligomers. The consequent inefficiency of secretion explains the accompanying deficiency and loss of function, but the severity of thrombosis associated with these mutations suggests that the oligomers also have new and undefined pathological properties that could be exacerbated by pregnancy or infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140129     DOI: 10.1111/j.1538-7836.2004.00749.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  13 in total

1.  Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation.

Authors:  Irene Martínez-Martínez; Adriana Ordóñez; José Navarro-Fernández; Angel Pérez-Lara; Ricardo Gutiérrez-Gallego; Rafael Giraldo; Constantino Martínez; Esther Llop; Vicente Vicente; Javier Corral
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

Review 2.  Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders.

Authors:  David H Perlmutter; Gary A Silverman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

3.  The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency.

Authors:  Irene Martínez-Martínez; José Navarro-Fernández; Sonia Aguila; Antonia Miñano; Nataliya Bohdan; María Eugenia De La Morena-Barrio; Adriana Ordóñez; Constantino Martínez; Vicente Vicente; Javier Corral
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

4.  Rare double heterozygous mutations in antithrombin underlie hereditary thrombophilia in a Chinese family.

Authors:  Haoyu Deng; Jiaquan Chen; Hui Xie; Yi Gu; Kai Yuan; Peng Wang; Wei Shen; Wei Liang; Hao Zhang; Jiwei Zhang; Jun Xie; Lan Zhang
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

5.  Antithrombin III deficiency in Indian patients with deep vein thrombosis: identification of first India based AT variants including a novel point mutation (T280A) that leads to aggregation.

Authors:  Teena Bhakuni; Amit Sharma; Qudsia Rashid; Charu Kapil; Renu Saxena; Manoranjan Mahapatra; Mohamad Aman Jairajpuri
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

6.  Transient desialylation in combination with a novel antithrombin deficiency causing a severe and recurrent thrombosis despite anticoagulation therapy.

Authors:  Nuria Revilla; María Eugenia de la Morena-Barrio; Antonia Miñano; Raquel López-Gálvez; Mara Toderici; José Padilla; Ángel García-Avello; María Luisa Lozano; Dirk J Lefeber; Javier Corral; Vicente Vicente
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

Review 7.  Serpins in thrombosis, hemostasis and fibrinolysis.

Authors:  J C Rau; L M Beaulieu; J A Huntington; F C Church
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

8.  Identification of antithrombin-modulating genes. Role of LARGE, a gene encoding a bifunctional glycosyltransferase, in the secretion of proteins?

Authors:  María Eugenia de la Morena-Barrio; Alfonso Buil; Ana Isabel Antón; Irene Martínez-Martínez; Antonia Miñano; Ricardo Gutiérrez-Gallego; José Navarro-Fernández; Sonia Aguila; Juan Carlos Souto; Vicente Vicente; José Manuel Soria; Javier Corral
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

9.  Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin.

Authors:  Sonia Aguila; Irene Martínez-Martínez; Gilda Dichiara; Ricardo Gutiérrez-Gallego; José Navarro-Fernández; Vicente Vicente; Javier Corral
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

10.  Intermittent C1-Inhibitor Deficiency Associated with Recessive Inheritance: Functional and Structural Insight.

Authors:  Sonia Caccia; Chiara Suffritti; Thomas Carzaniga; Romina Berardelli; Silvia Berra; Vincenzo Martorana; Annamaria Fra; Christian Drouet; Marco Cicardi
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.